IPSC
Price
$0.62
Change
+$0.06 (+10.71%)
Updated
Jun 6, 04:23 PM (EDT)
Capitalization
48.51M
62 days until earnings call
RXRX
Price
$5.38
Change
+$0.82 (+17.94%)
Updated
Jun 6, 04:39 PM (EDT)
Capitalization
1.85B
67 days until earnings call
Interact to see
Advertisement

IPSC vs RXRX

Header iconIPSC vs RXRX Comparison
Open Charts IPSC vs RXRXBanner chart's image
Century Therapeutics
Price$0.62
Change+$0.06 (+10.71%)
Volume$1K
Capitalization48.51M
Recursion Pharmaceuticals
Price$5.38
Change+$0.82 (+17.94%)
Volume$83.38K
Capitalization1.85B
IPSC vs RXRX Comparison Chart
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. RXRX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (IPSC: $0.56 vs. RXRX: $4.56)
Brand notoriety: IPSC and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 104% vs. RXRX: 146%
Market capitalization -- IPSC: $48.51M vs. RXRX: $1.85B
IPSC [@Biotechnology] is valued at $48.51M. RXRX’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • IPSC’s TA Score: 6 bullish, 3 bearish.
  • RXRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than RXRX.

Price Growth

IPSC (@Biotechnology) experienced а +1.08% price change this week, while RXRX (@Biotechnology) price change was +2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

IPSC is expected to report earnings on Aug 07, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.85B) has a higher market cap than IPSC($48.5M). RXRX YTD gains are higher at: -32.544 vs. IPSC (-44.257). IPSC has higher annual earnings (EBITDA): -117.21M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. IPSC (198M). IPSC has less debt than RXRX: IPSC (54.6M) vs RXRX (92.9M). RXRX has higher revenues than IPSC: RXRX (59.8M) vs IPSC (2.68M).
IPSCRXRXIPSC / RXRX
Capitalization48.5M1.85B3%
EBITDA-117.21M-524.77M22%
Gain YTD-44.257-32.544136%
P/E RatioN/AN/A-
Revenue2.68M59.8M4%
Total Cash198M500M40%
Total Debt54.6M92.9M59%
TECHNICAL ANALYSIS
Technical Analysis
IPSCRXRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JILL16.380.81
+5.20%
JJill
BMBL5.350.06
+1.13%
Bumble
CNI105.57-0.52
-0.49%
Canadian National Railway
CETY0.27-0.01
-2.90%
Clean Energy Technologies
ADT8.25-0.35
-4.07%
ADT

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-0.71%
CRSP - IPSC
56%
Loosely correlated
+1.37%
PRME - IPSC
49%
Loosely correlated
+3.79%
ABCL - IPSC
49%
Loosely correlated
-2.27%
IMNM - IPSC
49%
Loosely correlated
+1.16%
RXRX - IPSC
48%
Loosely correlated
-7.13%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-7.13%
CRSP - RXRX
72%
Closely correlated
+1.37%
BEAM - RXRX
63%
Loosely correlated
-0.87%
ABCL - RXRX
60%
Loosely correlated
-2.27%
ABSI - RXRX
60%
Loosely correlated
-0.35%
NTLA - RXRX
57%
Loosely correlated
-1.30%
More